An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ treatment, and many physicians are reluctant to ...

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

Testosterone testing and treatment have increased significantly over the past 2 decades, yet clinical practices remain inconsistent. 1,2 Despite rising awareness and prescription trends, up to 25% of ...

Routine gonadal and sexual health assessments are necessary in this population. Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, a new study ...

Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance.

Testosterone is the primary androgen — or male hormone — in your body. Low testosterone affects up to 39 percent of adult men in the US over the age of 45, and becomes increasingly prevalent as men ...